Iveric Bio Stock Equity Positions Weight
IVERIC Bio fundamentals help investors to digest information that contributes to IVERIC Bio's financial success or failures. It also enables traders to predict the movement of IVERIC Stock. The fundamental analysis module provides a way to measure IVERIC Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IVERIC Bio stock.
IVERIC |
IVERIC Bio Company Equity Positions Weight Analysis
IVERIC Bio's Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
CompetitionAccording to the company disclosure, IVERIC Bio has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
All Next | Launch Module |
IVERIC Fundamentals
Return On Equity | -0.55 | |||
Return On Asset | -0.3 | |||
Current Valuation | 4.98 B | |||
Shares Outstanding | 137.98 M | |||
Shares Owned By Insiders | 0.65 % | |||
Shares Owned By Institutions | 99.35 % | |||
Number Of Shares Shorted | 16.64 M | |||
Price To Earning | 4.17 X | |||
Price To Book | 3.81 X | |||
Gross Profit | (117.01 M) | |||
EBITDA | (192.28 M) | |||
Net Income | (185.21 M) | |||
Cash And Equivalents | 311.96 M | |||
Cash Per Share | 2.64 X | |||
Total Debt | 97.77 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 11.98 X | |||
Book Value Per Share | 3.48 X | |||
Cash Flow From Operations | (163.77 M) | |||
Short Ratio | 5.25 X | |||
Earnings Per Share | (1.82) X | |||
Target Price | 39.1 | |||
Number Of Employees | 163 | |||
Beta | 1.1 | |||
Market Capitalization | 5.51 B | |||
Total Asset | 666.82 M | |||
Retained Earnings | (864.81 M) | |||
Working Capital | 627.24 M | |||
Current Asset | 121.07 M | |||
Current Liabilities | 14.54 M | |||
Z Score | 32.19 | |||
Net Asset | 666.82 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in IVERIC Stock
If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |